News

Study startup underperformance and inefficiency has been a problem for executives who manage clinical research trials for decades.

Under the right conditions, full informed consent is not ethically required for some types of health research, according to leading bioethics experts.

ERT has been named a preferred provider for the administration of the EuroQol Group's EQ-5D patient reported outcome assessment.

Next week Europe will celebrate Rare Disease Day.

Awards for Excellence in Human Research Protection for 2013 were announced

Company broadens portfolio of regulatory information management solutions to enhance client value

PAREXEL has announced its Regulatory Outsourcing Services

VIAPhone Approved to Capture EuroQol Group's EQ-5D Assessments of Health Outcomes

New Jersey-based Integrated Clinical Systems, Inc. announced the opening of a European branch office in Lausanne, Switzerland.

In the world of electronic patient reported outcomes, many clinical trial sponsors are interested in the concept of Bring Your Own Device...

LabCorp has acquired Covance Genomics Laboratory and its associated genomic analysis business.

LabCorp acquired Covance Genomics Laboratory (CGL) and its associated genomic analysis business.

Integrated Clinical Systems, Inc. announced the opening of a European branch office in Switzerland

Strong working relationships between clinical trials sites and the CRO managing the study are critical to successfully executing a clinical trial.

Maintaining health and safety of patients is a primary objective when conducting any form of research.

Research and Markets recently released its Biosimilars Market by Product & Application - Global Forecast to 2018

Chiltern International Limited proudly announces partnership with Karolinska Development in Sweden

The newly formed ABIVAX is now working with the Cuban Center for Genetic Engineering and Biotechnology to develop therapeutic vaccines and antivirals.

Clinical program focused on reversing type 1 diabetes symptoms in patients diagnosed within six months of trial initiation

Regulations for the development of medical devices in Japan, China, and the UK will come under scrutiny

Clinical program focused on reversing type 1 diabetes symptoms in patients diagnosed within six months of trial initiation

Chiltern announces it was selected as the partner CRO for Karolinska Development

Therapeutically-Focused Clinical Development Team Leverages Technology-Amplified dCRO Model to Streamline Efficiencies, Reduce Development Costs

PAREXEL announced a group of initiatives that include a re-designed corporate website

Therapeutically-Focused Clinical Development Team Leverages Technology-Amplified dCRO Model to Streamline Efficiencies, Reduce Development Costs

"Your Journey. Our Mission." communicates company's new brand promise

The global market is segmented on the basis of products, applications, and services.